Literature DB >> 19632057

Innovative strategies for tissue engineered skin based on multiple growth factors gene transfection.

Xin Nie1, Mao-jin Yang, Man-jing Deng, Jian-shen Chai, Yan Jin, Lu-chuan Liu.   

Abstract

Tissue engineering combines the principles of cell biology, engineering and materials science to develop three-dimensional tissues to replace or restore tissue function. Tissue engineered skin (TE-skin) is one of most advanced tissue constructs. However, much clinical providence demonstrates the TE-skin may not be viewed as the equal of skin grafts, the contributions to accelerate the closure of wound were come mainly from various growth factor. These growth factors respond to its environment to bring about the desired effect. In our hypothesis, this three-dimensional skin substitute could be genetically modified with various growth factor and transplanted in order to deliver therapeutic proteins locally and systemically for the treatment of trauma. The likelihood of transgened TE-skin plays function as a pharmacological agent suggests a wide range of therapeutic applications. In future, the TE-skin could be design as gene delivery to enhance potential capacity for treatment of burns, chronic wounds and even systemic diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632057     DOI: 10.1016/j.mehy.2009.06.026

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

Review 1.  Towards organ printing: engineering an intra-organ branched vascular tree.

Authors:  Richard P Visconti; Vladimir Kasyanov; Carmine Gentile; Jing Zhang; Roger R Markwald; Vladimir Mironov
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

2.  LNGFR targets the Wnt/β-catenin pathway and promotes the osteogenic differentiation in rat ectomesenchymal stem cells.

Authors:  Gang Li; Junyu Liu; Yingying Wang; Kun Yang; Manzhu Zhao; Yong Xiao; Xiujie Wen; Luchuan Liu
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.